Australia markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
958.64+1.64 (+0.17%)
At close: 04:00PM EDT
959.99 +1.35 (+0.14%)
After hours: 07:28PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts23232626
Avg. Estimate10.611.8943.9247.22
Low estimate9.2710.436.4840.97
High estimate12.8614.3151.5355.84
Year ago EPS10.2411.5943.7943.92
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts20192626
Avg. Estimate3.37B3.56B13.82B14.94B
Low estimate3.15B3.34B13.04B13.92B
High estimate3.5B3.75B14.42B16.86B
Year ago salesN/A3.36B13.12B13.82B
Sales growth (year/est)N/A5.80%5.40%8.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS9.8410.7210.7310.09
Actual EPS10.2411.5911.869.55
Difference0.40.871.13-0.54
Surprise %4.10%8.10%10.50%-5.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate10.611.8943.9247.22
7 days ago10.9112.0245.1547.65
30 days ago10.9111.8944.847.36
60 days ago11.0411.9344.8347.29
90 days ago11.0912.0144.8346.95
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A2N/A1
Up last 30 days36611
Down last 7 daysN/AN/AN/AN/A
Down last 30 days7675
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.3.50%N/AN/AN/A
Next qtr.2.60%N/AN/AN/A
Current year0.30%N/AN/AN/A
Next year7.50%N/AN/AN/A
Next 5 years (per annum)9.90%N/AN/AN/A
Past 5 years (per annum)17.45%N/AN/AN/A